Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZAP Surgical Systems is a medical technology company that designs and manufactures the ZAP-X Gyroscopic Radiosurgery platform, a next-generation robotic stereotactic radiosurgery (SRS) system. Founded in 2014 by Dr. John R. Adler, the inventor of CyberKnife, the company aims to expand global access to non-invasive brain surgery by eliminating the need for costly, shielded radiation vaults and legacy Cobalt-60 radioactive sources. The ZAP-X platform utilizes a unique gyroscopic design and a modern linear accelerator to deliver high-dose, precise radiation to cranial tumors and other neurological conditions while sparing healthy brain tissue. Additionally, the company offers the FDA-cleared ZAP-Axon Radiosurgery Planning System, a streamlined, web-based software platform that accelerates and simplifies treatment planning using advanced optimization algorithms. ZAP Surgical is also pioneering new clinical applications of high-precision SRS for psychiatric and functional disorders, including treatment-resistant depression, addiction, and obesity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZAP Surgical.